Castle Biosciences DEF 14A Filing Details Executive Compensation
Ticker: CSTL · Form: DEF 14A · Filed: Apr 9, 2025 · CIK: 1447362
| Field | Detail |
|---|---|
| Company | Castle Biosciences Inc (CSTL) |
| Form Type | DEF 14A |
| Filed Date | Apr 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
TL;DR
Castle Biosciences dropped its DEF 14A, showing exec comp details for FY24. Check it out.
AI Summary
Castle Biosciences Inc. filed its DEF 14A on April 9, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and other corporate governance matters. Key financial data for the fiscal years 2020 through 2024 are included, with specific focus on compensation-related metrics for 2024.
Why It Matters
This filing provides shareholders with crucial information regarding how executive compensation is structured and approved, impacting corporate governance and investor confidence.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) that details executive compensation and corporate governance, not a filing indicating significant new risks or events.
Key Numbers
- 2024 — Fiscal Year (Primary focus for compensation data in this filing)
- 2020-2024 — Reporting Period (Range of fiscal years for which financial data is presented)
Key Players & Entities
- CASTLE BIOSCIENCES INC (company) — Filer of the DEF 14A
- 0001447362-25-000054 (filing_id) — Accession Number for the filing
- 20250409 (date) — Filing Date
- 20250522 (date) — Period of Report
- 2024-12-31 (date) — Fiscal Year End
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is filed by a company to solicit proxies from shareholders for an upcoming annual or special meeting of security holders. It provides detailed information about matters to be voted on, including director elections, executive compensation, and other corporate governance issues.
When was this DEF 14A filing submitted by Castle Biosciences Inc.?
Castle Biosciences Inc. filed this DEF 14A on April 9, 2025.
What fiscal year does this filing primarily cover regarding compensation data?
This filing primarily covers the fiscal year ending December 31, 2024, for compensation-related data.
What is the SIC code for Castle Biosciences Inc.?
The Standard Industrial Classification (SIC) code for Castle Biosciences Inc. is 8071, which falls under SERVICES-MEDICAL LABORATORIES.
Where is Castle Biosciences Inc. headquartered?
Castle Biosciences Inc. is headquartered at 505 S FRIENDSWOOD DRIVE, SUITE 401, FRIENDSWOOD, TX 77546.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 9, 2025 regarding CASTLE BIOSCIENCES INC (CSTL).